Analysis on the risk of muscle adverse events of PCSK9 inhibitors based on the FAERS database

doi:10.3969/j.issn.1672-3384.2024.01.016

PDF(369 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (1) : 76-81. DOI: 10.3969/j.issn.1672-3384.2024.01.016

Original Article

Analysis on the risk of muscle adverse events of PCSK9 inhibitors based on the FAERS database

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(1): 76-81 https://doi.org/10.3969/j.issn.1672-3384.2024.01.016

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(369 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-05-06	2024-01-31
Issue Date
2024-01-31

Please choose a citation manager

Content to export